C-LANT
Commercial- Indications
- Thoracic trauma, Post-operative drainage
Company intelligence / Profile preview
Vigor Medical Technologies has developed the C-Lant device, an innovative self-fixation port for rapid, safe treatment of chest trauma and post-operative thoracic drainage. The company has completed advanced prototypes, successful animal testing in collaboration with Israeli defense forces, and is preparing for regulatory submissions. No clinical trial results are published yet; FDA clearance will be sought via 510(k) pathway without full clinical trials.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vigor Medical Technologies.